Ad is loading...
CBUS
Price
$4.37
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
INZY
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
117 days until earnings call
Ad is loading...

CBUS vs INZY

Header iconCBUS vs INZY Comparison
Open Charts CBUS vs INZYBanner chart's image
Cibus
Price$4.37
Change-$0.00 (-0.00%)
Volume$93.51K
CapitalizationN/A
Inozyme Pharma
Price$2.69
Change-$0.00 (-0.00%)
Volume$371.49K
CapitalizationN/A
CBUS vs INZY Comparison Chart
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CBUS vs. INZY commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and INZY is a Buy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (CBUS: $4.14 vs. INZY: $2.81)
Brand notoriety: CBUS and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 41% vs. INZY: 147%
Market capitalization -- CBUS: $109.53M vs. INZY: $180.51M
CBUS [@Biotechnology] is valued at $109.53M. INZY’s [@Biotechnology] market capitalization is $180.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, CBUS is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • CBUS’s TA Score: 5 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, CBUS is a better buy in the short-term than INZY.

Price Growth

CBUS (@Biotechnology) experienced а -8.61% price change this week, while INZY (@Biotechnology) price change was -10.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

CBUS is expected to report earnings on Aug 09, 2023.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($181M) has a higher market cap than CBUS($110M). INZY YTD gains are higher at: -34.038 vs. CBUS (-78.921). INZY has higher annual earnings (EBITDA): -90.3M vs. CBUS (-492.98M). INZY has more cash in the bank: 132M vs. CBUS (28.8M). CBUS has less debt than INZY: CBUS (36.7M) vs INZY (46.8M). CBUS has higher revenues than INZY: CBUS (4.15M) vs INZY (0).
CBUSINZYCBUS / INZY
Capitalization110M181M61%
EBITDA-492.98M-90.3M546%
Gain YTD-78.921-34.038232%
P/E RatioN/AN/A-
Revenue4.15M0-
Total Cash28.8M132M22%
Total Debt36.7M46.8M78%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CBUSINZY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGIQ0.02N/A
+3.43%
LOGIQ INC.
MAKSY9.570.10
+1.06%
Marks & Spencer Group Plc
VWAGY8.780.04
+0.46%
Volkswagen AG
CKHUY5.07-0.06
-1.08%
CK Hutchison Holdings LTD
MDRX10.84-0.15
-1.36%
Veradigm Inc.

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with VRDN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-5.26%
VRDN - CBUS
36%
Loosely correlated
+2.96%
PSTX - CBUS
35%
Loosely correlated
+0.74%
INZY - CBUS
32%
Poorly correlated
+4.46%
MGTX - CBUS
32%
Poorly correlated
+0.17%
ETNB - CBUS
32%
Poorly correlated
+4.53%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+4.46%
BEAM - INZY
55%
Loosely correlated
+6.23%
DNLI - INZY
50%
Loosely correlated
+1.94%
FATE - INZY
50%
Loosely correlated
+10.63%
AVIR - INZY
49%
Loosely correlated
+3.69%
PLRX - INZY
49%
Loosely correlated
+1.01%
More